Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivitrol for methamphetamine addiction (A118G SNP)
NCT00984360Phase 2Completed
- Sponsor
- California Pacific Medical Center Research Institute
- Start
- Sep 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of naltrexone in methamphetamine use disorder (MUD), sponsored by California Pacific Medical Center Research Institute. Primary endpoint: Methamphetamine-negative Urine Samples at 5 weeks. Started Sep 2009; status: completed.
02
Drugs
naltrexone
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00984360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984360.